Apr 25, 2022
On this episode, we are joined by Dr. Carly Floyd, PharmD, AAHIVP, CDCES, TTS, to discuss HIV pre-exposure prophylaxis (PrEP). Dr. Floyd is a clinical pharmacist and the PGY1 community pharmacy residency program director at Southwest CARE center. She is also the clinical director at the University of New Mexico...
Apr 19, 2022
On this episode, we discuss the opportunistic infections that affect patients with HIV and low CD4 counts. We review coccidioidomycosis, pneumocystis, histoplasmosis, toxoplasma, cryptococcal meningitis, and mycobacterium avium complex (MAC).
Cole and I are happy to share that our listeners can claim ACPE-accredited...
Apr 12, 2022
On this episode, we are joined by Dr. Nina Lathia, BScPhm, RPh, MSc, PhD, to discuss the process of developing and managing a drug formulary. Dr. Lathia is a pharmacist and health economist in Toronto, Canada. She defines a drug formulary and explains some of the criteria used to establish a specific formulary. She...
Apr 4, 2022
On this episode, we review several drugs that have been approved by the FDA over the last year. The list of drugs that we review are below:
- Brexafemme (ibrexafungerp)
- Wegovy (semaglutide)
- Aducanumab (Aduhelm)
- Kerendia (finerenone)
- Zimhi (naloxone hydrochloride)
- Tyrvaya (varenicline) Nasal Spray
- PreHevbrio (hepatitis B...